COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION

Aim. To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard” (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, “Betaloc ZOK” (BZ), possibility of reaching target blood pressure (BP) le...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	J. V. Lukina, A. D. Deev, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, G. F. Andreeva, S. Y. Martsevich
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Столичная издательская компания 2015-12-01
Cyfres:	Рациональная фармакотерапия в кардиологии
Pynciau:	metoprolol tartrate metoprolol succinate arterial hypertension antihypertensive therapy
Mynediad Ar-lein:	https://www.rpcardio.online/jour/article/view/367
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!